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ABSTRACT Cells were microinjected with four mouse monoclonal antibodies that were di-
rected against either alpha- or beta-tubulin subunits, one monoclonal with activity against
both subunits, and a guinea pig polyclonal antibody with activity directed against both
subunits, to determine the effects on the distribution of cytoplasmic microtubules and 10-nm
filaments. The specificities of the antibodies were confirmed by Western blots, solid phase
radioimmunoassay, and Western blot analysis of alpha- and beta-tubulin peptide maps. Two
monoclonals DM1A and DM3B3, an anti-alpha- and anti-beta-tubulin respectively, and the
guinea pig polyclonal anti-alpha/beta-tubulin antibody (GP1T4) caused the 10-nm filaments
to collapse into large lateral aggregates collecting in the cell periphery or tight juxtanuclear
caps; the other monoclonal antibodies had no effect when microinjected into cells. The
filament collapsing was observed to be complete at 1 .5-2 h after injection. During the first 30
min after injection a few cytoplasmic microtubules near the cell periphery could be observed
by fluorescence microscopy. This observation was confirmed by electron microscopy, which
also demonstrated assembled microtubules in the juxtanuclear region . By 1 .5 h, when most
of the 10-nm filaments were collapsed, the complete cytoplasmic array of microtubules was
observed. Cells injected in prophase were able to assemble a mitotic spindle, suggesting that
the antibody did not block microtubule assembly. Metabolic labeling with [35S]methionine of
microinjected cells revealed that total protein synthesis was the same as that observed in
uninfected cells. This indicated that the microinjected antibody apparently did not produce
deleterious effects on cellular metabolism . These results suggest that through a direct inter-
action of antibodies with either alpha- or beta-tubulin subunits, 10-nm filaments were disso-
ciated from their normal distribution . It is possible that the antibodies disrupted postulated
10-nm filament-microtubule interactions.
l0-nm filament-microtubule interaction have been postu-
lated based on studies by electron microscopy (4, 17, 26, 32,
53, 55, 58), immunofluorescence microscopy (8, 24), and
biochemistry (43, 54, 55) in many eucaryotic cells. When cells
are incubated in the presence of antimicrotubule drugs, such
as colchicine, colcemid, or vinblastine, and cytoplasmic mi-
crotubules depolymerize (51) and the 10-nm filaments sub-
sequently coil into juxtanuclear caps (9, 26) or collapse into
large aggregates of filaments in the cytoplasm (12, 28, 33, 35).
Upon release from these drugs, the microtubules rapidly
reassemble into their original cytoplasmic array (51) and the
10-nm filaments then uncoil and redistribute with the major-
ity of microtubules (26). Although it is not known if these
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drugsdirectly affect the 10-nm filaments, it is thought that as
a result of microtubule depolymerization, 10-nm filaments
change their distribution due to a loss of interaction with the
assembled microtubules (27).
Several recent studies have shown that microinjection into
living cells of antibodies against the MT 95,000 component of
vimentin-l0-nm filaments (46) or antibodies directly made
against the 10-nm filament protein (23, 29) cause the fila-
ments to collapse. Although the cytoplasmic microtubules
appear to remain intact it is possible that by coating the 10-
nm filaments with antibody the filaments become cross-linked
to themselves and/or become dissociated from their normal
distribution. To further probe the possible interaction of 10-
847nm filaments with microtubules in vivo, we microinjected
cellswith monoclonal antibodies against either alpha- or beta-
tubulin, and one polyclonal antibody against both subunits.
In this paper we report that the microinjection of these
antibodies causes within 1 .5 h, the collapse of the 10-nm
filament cytoskeleton. The consequence ofmicroinjection did
not appreciably affect protein synthesis.
MATERIALS AND METHODS
Microinjection:
￿
Gerbil fibroma cells (IMR-33, CCL-146) were grown
on glass coverslipsas previouslydescàbed (6). Selected cells were microinjected
according to the method of Feramisco (18, 19). Antibodies for microinjection
were first concentrated by 40% ammonium sulfate precipitation, then dialyzed
exhaustively against microinjection buffer (90 mM KCI, 10 mM Na*/POe, pH
7.0), and then claàfied by centàfugation at 12,500 g for 10 min. The antibody
concentrations used for microinjection were ~ 10-20 mg/ml. Considering that
most mammalian tissue culture cells contain ~2 mg/ml tubulin or 2-3% of
the total cell protein (3l, 50, 59) and that -10% of the cell volume can be
microinjected (18, 30, 60) we estimate that approximately equal amounts of
antibody compared to endogenous tubulin were introduced into each cell.
PrOteiRS: Native microtubules were puàfied from freshly removed
brains of one day old chickens by three cycles of reversible temperature-
dependent assembly as descàbed before (7) after the method of Sloboda et al.
(57). The microtubules were furthersubjected to ion-exchange chromatography
on phosphocellulose (P-l 1; Whatman Laboratory Products, Inc., Clifton, NJ)
to isolate 6s tubulin after Sloboda et al. (57). The alpha- and beta-tubulin
subunits were separated on SDS-preparative gels containing 7.5% acrylamide-
0.195% bis-acrylamide and isolated by electroelution of the appropàate gel
bands (41). Eluted alpha- and beta-tubulin were precipitated three times with
80% acetone at 0-4°C for 0.5-I h and then dissolved in 125 mM Tàs-Cl (pH
6.8), O.l% SDS, and 1 mM EDTA, dialysed overnight against this buffer at
4°C, and stored at -70°C.
Vimentin was isolated from the gerbil fibroma cells by high salt-nonionic
detergent extraction as previously descàbed (11). Both vimentin and cycled
microtubules were used to preabsorb the antibodies in this study.
Monoclonal Antibody Production: BALB/C5, mice were im-
munized with native chick brain microtubules. The immunization schedule
per mouse to produce monoclonal antibodies DM1A and DM I B was the
following: day 0, 250 kg of protein emulsified in complete Freund's adjuvant
(CFA)- 90% of the dose given intrapeàtoneally (IP) and 10% given subcuta-
neously (SQ); day l4, 250 kg of protein emulsified in incomplete Freund's
adjuvant (ICFA) given IP and 100 ug of protein in phosphate-buffered saline
(PBS) given intravenously (IV); day 25, 175 Wg ofprotein in PBS given SQ and
175 ~g ofprotein in PBS given IV; day 28, the spleen was removed by steàle
technique and used for fusion. The immunization schedule to produce mono-
clonal antibodies DM3A I, DM3B3, and DM3B2 wasthe following: day 0, 350
ugofprotein emulsified in CFA- 90% of the dose given IP and 10% of the dose
given SQ; day 14, 175 wg of protein in PBS given IV and 200 kg of protein
emulsified in ICFA given IP; day 28, 175 ag ofprotein given IV and 250 ~g of
protein emulsified in ICFA given IP; day 42, 500-800 ~g of protein emulsified
in ICFA given SQ; day 58, I mg of protein in PBS, slowly given IV; day 61,
the spleen was removed and used for fusion. As determined by immunofluo-
resceneß staining ofcultured cells, only mice with high serum titers to tubulin
were selected for fusion.
Spleen cells were fused with the mouse myelomacell line NS-1 according to
the protocol of Kennett (37) as modified by Lin et al. (45) and plated into l6-
mm well Linbro cloning plates. After the hybàdoma cells had reached 50-75%
confluency, the supernatants were tested by immunofluorescence staining of
methanol fixed (-20°C, 10 min [52]) gerbil fibroma cells. A positive well was
considered to give intense staining ofthe interphase cytoplasmic microtubules
and mitotic spindles. The hybàdoma cells from these positive wells were grown
up in Dulbecco's modification of Eagle's medium containing 20% fetal calf
serum, 100 ~M hypoxanthine, and 25 kM thymidine. The cells were cloned
three times in sofr agar with gerbil fibroma cells used as a feeder layer after the
method of Lin et al. (45). After cloning approximately 105 to 106 hybàdoma
cells wereinjected intraperitoneally into BALB/C micethat hadbeen previously
( l wk) pàmed with 0.5 ml of Pàstane (2,6,10,14-tetramethyl pentadecane,
Aldàch Chemical Co., Milwaukee, WI). Very high titer mouse ascites fluid
were then collected and used as the source of antibody.
To determine the type of heavy chain and light chain each monoclonal
antibody was, hybàdomms were grown in 60-mm diameter culture dishes. The
supernates from confluent dishes were collected and made 40% ammonium
sulfate by the addition of the solid salt. The precipitates were redissolved in a
small volume of PBS and dialyzed overnight against PBS. The antibody was
UYH
￿
THE JOURNAL OF CELL BIOLOGY ~ VOLUME 9H, 19$4
then placed in the center well of a double immunodiffusion plate containing
I % agarose equilibrated with PBS. The surrounding outer wells contained goat
IgG (Litton Bionetics, Inc., Kensington, MD) specific for the vaàous classes of
mouse heavy and light chains Ig. Hybàdoma cells were also metabolically
labeled with ['SS]methionine (50 ~Ci per 16-mm diameter well) for 24 h in
methioniné-free media. Well supernatants were collected and subjected to
Stapholoccocus aureus immunoprecipitation with goat-anti-mouse immuno-
globulins as previously descàbed (10). The precipitates were analysed by
fluorography (13) on two-dimensional gels.
The pH ofelution of the monoclonal antibodies bound to protein-A seph-
arose (Pharmacia Fine Chemicals, Piscataway, NJ) was determined at two pH
ranges: pH 6.25 and 3.10. The monoclonal antibodies were made 0. I M Na*/
POD, pH 8.0 and were loaded onto a protein-A sepharose column equilibrated
with the same buffer. The column was washed with 4 bed vol ofpH 8.0 buffer,
then eluted with two successive step gradients of 0.1 M Na*/PO,-, pH 6.25,
and l50 mM NaCI, 100 mM acetic acid, pH 3.10. Column fractions were
analysed on SDS-gels.
"Western" Immunoblots: western immunoblots (14) were per-
formed as descàbed (8). Afterthe stacking gel was removed, transfer ofproteins
from SDS gels to 0.45 pm Millipore nitrocellulose paper was done for 70-80
min at 90 V. The nitrocellulose paper was then incubated in 3% BSA, (bovine
serum albumin, Sigma grade V) made in TBS (Tàs-buffered saline: 150 mM
NaCI, 50 mM Tàs-CI, 0.1 % sodium azide, pH 7.5) for 12 h at 4°C. Monoclonal
antibodies were diluted 1 :1,000 in 3% BSA/TBS and applied to the nitrocel-
lulose stàps in a humidified chamber. After incubation for 1 h at 20°C, the
strps were washed in five changes ofTBS over 2 h and once in 3% BSA/TBS.
,zsl-labeled goat IgG-anti-mouse immunoglobulins (against all heavy and light
chain classes of immunoglobulins [Cappel Laboratoàes, Inc., Cochranville,
PA]) was used at l06 cpm/ml in 3% BSA/TBS and applied to the nitrocellulose
stàps for 1 h at 20°C. The stàps were then washed with five changes of TBS
and dàed. Autoradiograms ofthe nitrocellulose stàps were made by exposing
Kodak XAR-5 film with a Dupont Cronex Lighting-Plus AC screen for 3-12
h at -70°C. Westernblots analysing polyclonalguineapig anti-tubulin (GP174)
were prepared as previously descàbed (8). Proteins transferred to nitrocellulose
strips were visualized by Amido black staining (8).
Solid Phase Radioimmunoassay:
￿
To each weu ofa 96 well poly-
vinyl chloàde microtiter plate (Microtiter Plates cat. no. 1-220-24, Dynatech
Laboratoàes, Inc., Alexandàa, VA) 2.5 kg of alpha-tubulin, beta-tubulin, or
CCL-146 vimentin was added in 50 kl of coupling buffer (50 mM NazC05,
0. I % sodium azide, pH 9.6), and coupled for 12 h at 4°C. The wells were then
washed three times with 100 ~I of 1 mg/ml BSA in TBS. To each well was
added 50 ~l of monoclonal antibody at the following dilutions: 1:200, 1:400,
1:800, 1:1,600, 1:3,200, 1 :6,400, 1:12,800, and 1 :25,600, and incubated for 1 h
at 20°C. Following three washes with 100 kl of0.05% Tween-80 in TBS, each
well received 50 kl of ,zSI-labeled goat anti-mouse (l05 cpm/well) and was
incubated for 1 h at 20°C. The wells were then washed three times with 0.05%
Tween-80 in TBS, dàed, and counted. A mouse antivimentin monoclonal
SBV21 (IgG,) was used as a control in the vimentin radioimmunoassay (RIA).
SDS PAGE and Peptide Maps:
￿
Total cell lysates were made by
directly homogenizing cultured gerbil fibroma cells in SDS-sample buffer (2%
SDS, 80 mM Tàs-Cl, l00 mM dithiothreitol, 15% glycerol, pH 6.8)and rapidly
placingthe sample in a boiling water bath for 5 min. Samples were then loaded
into slots of a l2% acrylamide-0.1 % bis-acrylamide analytical SDS-gel using
the Laemmli (40) buffer system and the Blattier et al. (5) gel formulation;
electrophoresis in the separating gel was conducted at 250 V and gels were
stained with Coomassie Blue as descàbed (11).
Peptide maps ofnative chick brain 6s tubulin were generated by enzymatic
cleavage with S. aureus V8 protease (V8) or chymotrypsin after the method of
Cleveland et al. ( IS) modified to allow the digestion to occur under native
conditions without SDS. To 134.8 kg of 6s tubulin was added 7 Wg of V8
protease (Worthington Biochemcals, Freehold, NJ) in a final volume of 500 ul
in buffer (50 mM PIPES-KOH, 0.5 mM MgSO,, 1 mM EGTA, pH 6.9). The
mixture was incubated for 30 min at 37°C and the reaction was terminated by
the addition of an equal volume of 2X SDS-sample buffer and incubation in a
boiling water bath for 5 min. Approximately 30 ~1 ofsample were applied per
get slot. In a similar manner 10.5 Wg ofchymotrypsin (TLCK-treated, Worth-
ington Biochemicals) was added to 134.8 kg of 6s tubulin in a final volume of
500 kl of buffer, incubated for 30 min at 37°C; and the reaction terminated as
descàbed above. About 30 ~l of sample were applied per slot. Peptides were
electrophoresed on SDS-gels and then transferred to Western blots as descàbed
above. Peptide maps ofeluted-SDS denatured alpha- or beta-tubulin were done
according to Cleveland et al. (IS). To 114 kg of alpha-tubulin or 113 ~g of
beta-tubulin was added 1 ~g ofV8 protease in a final volume of200 pl in 0.1
SDS, 125 mM Tàs-Cl, 1 mM EDTA, pH 6.8. The mixture was incubated for
30 min at 37°C, then terminated as descàbed above, and 30 gal of sample were
applied per gel slot. To 114 ug of alpha-tubulin or l 13 pg of beta-tubulin was
added 5 kgofchymotrypsin in a final volume of200 KI of buffer, and incubatedfor 1 h at 37°C; the reaction was terminated and 30 ~I of sample were applied
per slot .
M, standards used were the following : chick brain microtubule associated
proteinsM 300,000 ; myosin heavy chain M, 200,000 ; beta-galactosidaseM
116,500 ; phosphorylase-b M~ 94,000; bovine serum albuminM 68,000 ; chick
brain alpha-tubulinM 57,000 ; chick brain beta-tubulin M, 54,000; actin M,
45,000 ; ovalbumin M,43,000 ; carbonic anhydraseM30,000; soybean trypsin
inhibitor M, 21,000 ; and lysozymeM 14,300 as previously described (8) .
( 355]Methionine Microlabeling of Microinjected Cells and
Two-Dimensional Gel Electrophoresis : For microtabeling, afrer
the method ofClevelandet al . (16), a 250 ~Ci aliquot of["S]methionine (>600
Ci/mmol, Amersham cat. no. SJ235 ; dissolved in water containing 0.1% 2-
mercaptcethanol) was placed in a sterile 1 .8 ml NUNC vial, frozen in liquid
nitrogen, and lyophilized. The label was then dissolved in 25 rrl of culture
media lacking methionine and used immediately for microlabeling of cells .
Glass chips of < I mm 2 were prepared by breaking sterile glass coverslips
with forceps. Cells were then seeded onto these coverslips at a low density so
that between 20-30 cells attached per glass chip . The chips were then kept in
35-mm culture dishes and 24-48 h postplating all the cells on selected chips
were microinjected with antibodies. The chips were then placed inthe incubator
for I .5-2 h . The chips were then removed from the dish with sterile jewelers
forceps and rinsed twice, 30 s each, in 37°C tissue culture media lacking
methionine . The chip was then placed into a 10-k1 drop of labeling media
(-methionine) containing 100 pCi [' SS]methionine . The drop was on a sruall
square of Parafilm in a 35-mm culture dish . After labeling for an additional 2
h in the tissue culture incubator, the chip was rinsed twice in warm media
containing unlabeled methionine. At each step during the labeling the cells on
the chip were checked by phase-contrast microscopy to determine that they
were not damaged .
The chip was then directly placed into 20 ~1 of hot ( l00°C) SDS-sample
buffer in a 1 .5 ml Eppendorf tube and scrapped with an Eppendorf plastic
micropipette . The sample (plus the glass chip) was rapidly placed on a boiling
water bath for 5 min, the chip was then removed, the sample frozen in liquid
nitrogen, and lyophilized . The sample was then dissolved into 50 ~1 of two-
dimensional sample buffer (9.95 M urea, 4% Nonidet P-40, 2% ampholines
pH 5-7, l00 mM dithiothreitol, and 0.3% SDS) at 37°C for 30 min . Acrylamide
isoelectric focusing gels were cast with pH 5-7 ampholines and the second
dimension was electrophoresed on 10% acrylamide SDS-gels after Garrets (22).
Gel fluorography was performed as modified for [' SS]methionine-labeled pro-
teins (22) . Two-dimensional gels were loaded with _ 120,000 cpm oftrichloro-
acetic acid precipitable counts. The fluorograms were exposed for 1 month at
-70°C . Two-dimensional gels of the monoclonal heavy and light chains were
analysed with pH 3-10 ampholines and 12% acrylamide-SDS gels .
Indirect Immunofluorescence and Polyclonal Antibod-
ie5 :
￿
Cells were fixed and stained for indirect immunofluorescence as previ-
ously described (6) . For double label indirect immunofluorescence, comparing
the distribution of two different antibodies in contrasting fluorcehromes-
fluorescein isothiocynate (FITC) and tetramethyl rhodamine isothiocynate
(TMRITC), rabbit IgG-anti-vimentin (#240) in TMRITC and guinea pig IgG-
anti-tubulin (GP l T4) in TMRITCwere used as described (7) and the specificity
ofthese antibodies has been described elsewhere (8) . To analyse the distribution
of mouse monoclonal antibodies, we used FITC-goat anti-mouse (Cappel
Laboratories, Inc., Cochranville, PA)at ~0 .7 mg/ml . To reducethe observation
of FITC-stimulated TMRITC fluorescence, we included the Zeiss barrier filter
BP 520-560 (cat . no . 46-79-94-9903) in the epifluorescence nose piece module.
Electron Microscopy:
￿
Microinjected cells were circled with an ,nk
ring on the outside bottom of the culture dish using an inverted phase-contrast
microscope . At selected times after microinjection the cells were fixed and
processed for electron microscopy after Blow and Chacko (9). Serial en face
sections ofthe cells were prepared (80-100 nm thick) and examined in a Philips
201 electron microscope .
RESULTS
Antibody Characterization
By double immunodiffusion analysis the monoclonal
mouse immunoglobulin class was determined : DM1A,
DM1B, DM3A1, and DM3B3 were IgG, with kappa-light
chains ; and DM3B2 was an IgM . DM1A and DM3A1 eluted
from protein-A sepharose at pH 6.25, andDM1B andDM3B3
eluted at pH 3.10 (Table I) . DM3B2, an IgM, did not bind to
protein-A Sepharose . The metabolically labeled [ 35S]methio-
nine monoclonals were immunoprecipitated with goat anti-
mouse/S. aureus to examine that each clone secreted only
one antibody . As observed by two-dimensional gels (Fig. 1)
each clone gave rise to a unique set oflight and heavy chains .
To verify the specificities of the monoclonal antitubulins,
we performed several analyses: the antibodies were analysed
on Western blots of tubulin subunits, total cell lysates, V8,
and chymotryptic peptide peptide maps of SDS-denatured
alpha-tubulin, and beta-tubulin, and peptide maps of native
6s tubulin, and by binding to alpha-tubulin, beta-tubulin, and
vimentin in a solid phase RIA.
DM 1A and DM3A 1 were anti-alpha-tubulins as deter-
mined by Western blots of tubulin subunits and total cell
lysates (Fig . 2) . Both bound to the same set ofV8 peptides of
SDS-denatured alpha-tubulin (an example of this type of
experiment for the analysis of DM1A binding to V8 and
chymotryptic fragments of alpha- and beta-tubulin is shown
TABLE I
Characteristics of Microinjected Antitubulin Antibodies
ND, not determined .
FIGURE 1
￿
Fluorogram of two-dimensional gels of S. aureus immu-
noprecipitates of the monoclonal antitubulins metabolically labeled
with ['sS]methionine . Each monoclonal produced a heavy chain
(HC) and light chain (LC) with unique isoelectric points . The im-
munoglobulin class was determined by double immunodiffusion
analysis : (A) DM1A, (8) DM1B, (C) DM3A1, and (D) DM3B3 were
IgG, with HC, (M,
￿
53,000) and LC, (M,
￿
25,000) . (E) DM3B2 was
an IgM with HC (M,
￿
72,000) . (F) DM1A (a) and DM1B (ß) were
mixed to show the distinct electrophoretic mobilities of the HC and
LC. Isoelectric focusing gels contained pH 3-10 ampholines .
BLOSr rT AL .
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849
Microin-
Prot-A Tubulin jection :
Sepha- subunit effect on
rose elu- specific- 10 nm-
Ig-class fion pH ity filaments
Monoclonal antibody
DM1A IgG, 6.25 a +
DM3A1 IgG, 6.25 a -
DM1B IgG, 3 .10 ß -
DM3B3 IgG, 3 .10 ß +
DM3B2 IgM ND a and ß -
Polyclonal antibody
GP1T4 IgGs ND a and ß +FIGURE 2 Western blot analysis of the monoclonal antitubulin
binding to a total cell lysate of the CCL-146 cells and standard
proteins containing brain alpha- and beta-tubulin . (Lane A) . The M,
standards x 10- ' ; 57~ and 54ß corresponding to alpha- and beta-
tubulin, respectively . (Lane 8) The total cell lysate . Both of these
lanes were 12% SDS gels stained with Coomassie Blue . (Lanes C
and D) The blots of A and B, respectively, stained with Amido black.
Monoclonal antibody blots of these lanes (s, M, standards corre-
sponding to lane A ; and c, cell lysate corresponding to lane 8)
revealed that DM1A and DM3A1 stained alpha-tubulin ; DM1 B and
DM3B3 stained beta-tubulin ; DM3B2 stained predominantly alpha-
tubulin . The last two lanes(DMIA+DMiB) show that the mixing of
DM1A with DM1B stained both tubulin subunits .
in Fig. 3) and the same set of V8 or chymotryptic peptides
generated from native 6s tubulin (Fig . 3) . DM3A1 recognized
the same set of chymotryptic peptides of SDS-denatured
alpha-tubulin asDM 1A plus a unique peptide atM~ 20,000
(Fig. 3). The specificity ofDM1A and DM3A1 were further
confirmed as anti-alpha-tubulins by solid phase RIA (Fig. 4) .
DM 1 B had strong binding predominantly to beta-tubulin
on Western blots (Fig . 2), although it weakly recognized an
alpha-tubulin V8 peptide derived from native 6s tubulin (Fig.
3) . This peptide was recognized by the other anti-alpha-
tubulins-DM 1A and DM3A 1 (Fig . 3) . On chymotryptic
peptide maps of native 6s tubulin, DM 1 B recognized a single
peptide that was also recognized by DM3B3, an anti-beta
tubulin (see results below) . DM1B recognized chymotryptic
fragments of SDS-denatured beta-tubulin only (Fig . 3). The
peptides of beta-tubulin generated by V8 protease were not
recognized by DM 1 B . By solid phase RIA, DM 1 B bound 14
times more counts to beta-tubulin that to alpha-tubulin (Fig .
4) . A similar result has been described for a monoclonal anti-
beta-tubulin (TUB 2.5) with secondary activity against alpha-
tubulin by Gozes and Barnstable (29) .
DM3B3 was an anti-beta-tubulin as determined by Western
blots of tubulin subunits and total cell lysates (Fig . 2) . It did
not bind to V8 peptides of native 6s tubulin, but bound to
the same chymotryptic peptides detected byDM 1 B (Fig. 3) .
DM3B3 detected the same chymotryptic peptides of SDS-
denatured beta-tubulin as recognized by DM1B (Fig . 3) . As
with DM 1B, DM3B3 did not recognize any oftheV8 peptides
(Fig. 3) . This possibly indicates that the V8 protease destroys
the antigenic site . On solid phase RIA, DM3B3 reacted
HSO
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strongly with beta-tubulin (Fig. 5) ; activity against alpha-
tubulin was not detected.
DM3B2, an IgM, on Western blots recognized predomi-
nantly alpha-tubulin brain subunits and alpha-tubulin of
CCL-146 cell lysates (Fig. 2) . On peptide maps of native 6s
tubulin, DM3B2 detected peptides recognized by both the
monoclonals against alpha- and beta-tubulin (Fig. 3) . When
DM3B2 was analysed on V8 and chymotryptic maps of SDS-
denatured alpha- or beta-tubulin, it recognized the same
peptides ofalpha-tubulin as detected by DM 1A and DM3A 1,
and it recognized peptides of beta-tubulin that were different
from those detected by DM1B and DM3B3 (Fig. 3) . On solid
phase RIA, DM3B2 bound 3.5 times more counts to alpha-
tubulin than to beta-tubulin (Fig. 4), Therefore, DM3B2 has
activity against both alpha- and beta-tubulin subunits .
All of the monoclonals against tubulin did not detect vi-
mentin on Western blots or on solid phase RIA (Fig . 4). The
guinea pig polyclonal antitubulin (GP1T4) had both anti-
alpha- and anti-beta-tubulin binding (8) (also see Fig . 8D).
Microinjection
Interphase gerbil fibroma cells arrange their 10-nm fila-
ments and microtubules in similar coincident cytoplasmic
arrays that span radially from the nucleus to the cell's border
(Fig. 5). When these cells were microinjected with monoclonal
DM1A or DM3B3 (Figs . 6 and 7), or with the polyclonal
GP1T4 (Fig . 8), within 2-3 h in ~50% of cells the 10-nm
filaments had collapsed into tight lateral aggregates observed
in the cell periphery or cell processes (Fig . 6, A-F) . In the
other 50% of the cells the 10-nm filaments had withdrawn
into tight juxtanuclear caps (Fig . 7, A-F) . Within the first 30
min after injection only a few prominent microtubules could
be observed near the cell nucleus because the injected anti-
body obscured the visualization, however microtubules near
the cell periphery could be observed (Fig . 9). After ~ 1 .5 h,
the complete cytoplasmic array of microtubules could be
observed in the same cells containing the cap of 10-nm
filaments inajuxtanuclear position (Fig. 9) . 3 h postinjection
the 10-nm filaments remained collapsed and the microtubules
maintained their usual cytoplasmic distribution (Figs. 6-9) .
Since it was difficult to assess microtubule distribution in the
first 30 min after microinjection by fluorescence microscopy,
microinjected cells were examined by serial section in the
electron microscope . In all cases, microinjected cells showed
assembled microtubules near the nucleus as well as the cell
periphery (Fig . 10) . This microtubule distribution was the
same as that observed in control-injected or control-unin-
jected cells . As observed in Figs. 6, B and E, and 7, C and E,
the distribution of the collapsed or capped 10-nm filaments
could be delineated when the cells were viewed for the distri-
bution of microtubules with FITC . These filaments were,
however, red in color and could be observed because the
overlap of the FITC emission (62) with the excitation wave-
length of the TMRITC-antivimentin . The red fluorescence
was strong enough to penetrate through the barrier filter
("bleed-through") because the vimentin staining of the col-
lapsed 10-nm filaments was intense .
If these antibodies were first preabsorbed with assembled
microtubules and then injected, the 10-nm filament collapsing
was abolished, while preabsorption with CCL-146 vimentin
had no effect on collapsing (Fig. 11) . The microinjection of
DM1B, DM3A1, or DM3B2 under identical conditions ap-FIGURE 3
￿
(A) Western blot analysis of monoclonal DM1A binding to V8 peptides (V8) and chymotryptic peptides (Chymo) of
SDS-denatured chick brain alpha-tubulin and beta-tubulin as an example of how all the monoclonal antibodies were analysed .
Peptides were prepared as described in Materials and Methods and chromatographed on a 15% acrylamide SDS-gel . Lane S
contains the M, standards x 10- ' ; Tub, indicates the position of the tubulin subunits . Lane A contains the V8 peptides generated
from a-tubulin; lane 8 contains the chymotryptic peptides generated form alpha-tubulin . Lane C contains the V8 peptides of
beta-tubulin and lane D contains the chymotryptic peptides of beta-tubulin . These lanes are stained with Coomassie Blue . After
transfer of the peptides a similar gel was stained with Coomassie Blue (Post-Trans) to observe the remaining peptides . Most of
the peptides were transferred . The nitrocellulose blot (Blot) of the gel stained with Amido black showed the major peptides had
transferred . DM1A stained a few of the alpha-tubulin peptides generated by V8 protease and chymotrypsin ; it did not detect any
beta-tubulin peptides . All of the monoclonal antibodies were analysed in a similar fashion on peptides generated from denatured
subunits and from native 6s tubulin . All antibodies used for the Western blots were diluted 1 :1,000 . (B) Summary of antibody
binding to proteolytic fragments of SDS-denatured chick brain alpha- and beta-tubulin . Lane S contain the M, standards x 10-3;
Tub, indicates the position of alpha- and beta-tubulin subunits . Lane A contains theVS proteolytic fragments (V8) of alpha-tubulin
and lane B contains the proteolytic fragments of alpha-tubulin digested with chymotrypsin (Chymo) . Lane C contains the VS
proteolytic fragments (V8) of beta-tubulin and lane D contains the chymotryptic fragments (Chymo) of beta-tubulin . *1 indicates
the position of an alpha-tubulin chymotryptic peptide bound by DM3A1, *2 a beta-tubulin chymotryptic peptide bound by
DM3B2, and *3 a beta-tubulin chymotryptic fragment bound by DM1B that were all detected on Western blots, but were not
visualized in the Coomassie-Blue-stained gels . (C) Summary of antibody binding to proteolytic fragments of chick brain native 6s
tubulin . Lane S contains the M, standards x 10-3; Tub, indicates the position of the native 6s tubulin molecule . Lane A contains
the VS protease fragments (V8) generated from 6s tubulin . Lane 8 contains the chymotryptic peptides (Chymo) generated from
6s tubulin . The arrowheads on lanes A and 8 indicate the positions of the major peptides to which the antibodies bind . The
asterisk (*) indicates some diminished binding ofDM3B3 to the parent molecule relative to DM1B. The symbols in the Key are
used to identify the respective antibody binding to the peptide fragments . The SDS-gels were 15% acrylamide .
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FIGURE 4
￿
(A) Solid-phase RIA analysis of monoclonal antitubulins binding to chick brain a-tubulin . DM1A and DM3A1 bound
the largest number of counts to alpha-tubulin, followed by DM3B2. DM1B bound a small number of counts above background
to alpha-tubulin . DM3B3 bindingwas not detected . (8) Solid phase RIA analysis of monoclonal antitubulins binding to chick brain
beta-tubulin . Both DM1B and DM3B3 bound large numbersof counts to beta-tubulin, with lower binding of DM3B2. DM1A and
DM3A1 binding were not detected . (C) Solid-phase RIA of monoclonal antitubulins binding to vimentin from CCL-146 cells . No
binding to vimentin could be detected for the monoclonal antitubulins . SBV21, a mouse monoclonal (IgG,) to vimentin, was
included as a control . Thesymbols in theKey refer to the respective monoclonal antitubulins . Bkgd, indicates background counts .
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851FIGURE 5
￿
Phase-contrast (A) and fluorescent micrographs (B and C) of a control (uninfected) CCL-146 cell indirectly stained for
vimentin with #240 antibody labeled with TMRITC (B) and for tubulin with DM3B3, monoclonal anti-,ß-tubulin, labeled with FITC
(C). The distribution of vimentin filaments and microtubules is nearly coincident . Nu, nucleus . x 800 .
FIGURE 6 (A-F) Fluorescence micrographs of cells microinjected with DM3B3, monoclonal anti-beta-tubulin, and stained to
observe the vimentin filament distribution at ~3 h after injection . Each triplet, (A-C and D-F, represents the same cell stained for
the distribution ofDM3B3 with FITC goat anti-mouse (8 and E) and for the vimentin filaments with TMRITC labeled antivimentin-
#240 (C and F) . These cells represent the typical distribution of the vimentin filaments (collapsed) after being injected with
monoclonal antitubulins that cause filament aggregation . The vimentin filaments were observed to collapse and aggregate in cell
processes (C) or along the lateral margins of the cell periphery (F) . B and E show the diffuse distribution of the microinjected
antibody within the cytoplasm, however the outline of the collapsed 10-nm filaments (red in color) were observed due to FITC-
stimulated TMRITC-fluorescence (see Results) . (G-/) fluorescence micrographs of two metaphase cells 30 min after microinjection
with DM3B3 . Each pair, G-H and 1-/, represents the same cell stained for the distribution of DM3B3 with FITC goat anti-mouse
(G and 1) and for vimentin filaments with TMRITC labeled #240 antivimentin (H and 1) . DM3B3 was visualized on the metaphase
spindle microtubules (G and 1) ; the antibody did not block assembly of the spindle to this stage . The distribution of vimentin
filaments formed a cage around the spindle (28) and was not affected by the injected antitubulin . (A-F) x 300 . (G-1) x 350 .
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THE JOURNAL OE CELL BIOLOGY " VOLUME 9S, 1984FIGURE 7 (A-F) Fluorescent micrographs of cells microinjected with DM3B3, monoclonal anti-beta-tubulin, and stained to
observe the vimentin filament distribution at 30 min (A and B), 1 .5 h (C and D), and 3 h (E and F) after injection . Each pair, A and
B, C and D, and Eand F represents the same cell stained for the distribution of DM3B3 with FITC-labeled goat anti-mouse (A, C,
and E) and for the distribution of the vimentin filaments with TMRITC-labeled anivimentin-#240 (B, D, and F) . At each time point
the injected DM3B3 (A, C, and E) was found to be diffusely distributed in the cytoplasm . Within the first 30 min after injection
the vimentin filaments (B) appeared to have the same distribution as the uninjected cell (see Fig . 4B) . By 1 .5 h after injection (D)
the vimentin filaments had collapsed next to the nucleus . At 3 h after injection (F) the vimentin filaments had completely moved
into a tight cap next to the nucleus . In C and E the outline of the 10-nm filament caps (red in color) were observed due to the
FITC-stimulated TMRITC-fluorescence (see Results) . (G-l) Fluorescence micrographs of cells microinjected with DM1B, mono-
clonal anti-beta-tubulin, and stained to observe the vimentin filament distribution ~3 h after injection . Each pair, G and H and I
and ), represents the same cell stained for the distribution of vimentin filaments with TMRITC-labeled antivimentin-#240 (G and
1) and for the distribution of DM1 B with FITC-labeled goat anti-mouse (H and /) . In the injected cells (*) DM1 B appeared to have
no effect on the vimentin filament distribution (G and l) as compared to uninjected cells (arrowheads) . The monoclonal antibody
could be seen on peripheral microtubules but a diffuse fluorescence was observed near the nucleus (H and /) . This was a
representative example of the microinjected monoclonal antibodies that produced no apparent effect on the vimentin filament
distribution (i.e ., DM3A1, DM3B2, and DM1 B) . (A-F) x 325 . (G-/) x 500 .
FIGURE 8 Fluorescence micrographs of CCL-146 cells microin-
jected with polyclonal guinea pig antitubulin (GP1T4) and stained
to observe the vimentin filament distribution (A, 8, and C) 3 h
postmicroinjection . In each case (A, B, and C) the filaments were
induced to collapse into aggregates in the injected cell (') as
compared to uninjected cells (arrowheads) . Western blot analysis
of the polyclonal antitubulin, GP1T4 (D) . Lane 1, are the M, stand-
ards x 10- ', including chick brain alpha-(57~) and beta-(54y) tubulin;
lane 2, represents the total CCL-146 cell lysate with the position of
vimentin indicated by the dark circle ; and lane 3, partly purified
CCL-146 vimentin (v) isolated by high salt-non ionic detergent
extraction (11) . These lanes are stained with Coomassie Blue (Stain)
and correspond to the same lanes on the Western blot (Blot) . The
polyclonal antitubulin stained both the alpha and beta subunits
from chick brain (Blot, lane 1) and CCL-146 cells (Blot, lane 2) ; the
antibody had no reaction with CCL-146 vimentin (Blot, lane 3) .
(A-8) X 450.
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￿
Fluorescence micrographs of cells microinjected with DM3B3 (monoclonal anti-ß-tubulin) and stained to observe the
microtubule distribution at 30 min (A and 8), 1 .5 h (C and D), and 3 h (E and F) after injection . Each pair, A and 8, C and D, and
E and F, represent the same cell stained for the distribution of DM3B3 with FITC-labeled goat anti-mouse (A, C, and E) and for
the distribution of microtubules probed with TMRITC-labeled guinea pig antitubulin (GP1T4) (8, D, and F) . At each time point
the injected DM3B3 (A, C, and E) was found diffusely distributed in the cytoplasm . Within the first 30 min after injection the
microtubules (e) were hard to visualize with GP1T4, except in the cell periphery (arrowheads) . At 1 .5 h postinjection (D)
microtubules were observed in their normal radial array ; and by 3 h postinjection the microtubules maintained their normal
cytoplasmic distribution (F) at a time when the vimentin filaments were maximally collapsed . x 700 .
peared to have no effect on the distributions of 10-nm fila-
ments or microtubules (Fig . 7, G-J; Table I) . In controls, cells
injected with microinjection buffer or monoclonals against
tropomyosin appeared to have no effect .
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Several cells were injected in early prophase with DM3B3
and then fixed in metaphase . It appeared that the microtu-
bules could assemble into a mitotic spindle that was sur-
rounded by a 10-nm filament cage (Fig. 6, G-J) .FIGURE 10 Electron micrographs of cells serially sectioned en face 30 min after microinjection with DM3B3 . Abundant
microtubule profiles were observed (between arrowheads) coursing through the cytoplasm for several micrometers near the
nucleus (A and 8) . Occasionally cross-sectional profiles of microtubules could be observed (within the circle indicated by double
arrowheads) near the nucleus (8) . In the peripheral cytoplasm numerous microtubules (between arrowheads) were observed as
well as microfilaments (mf) (C) . Near the ventral surface of the cell (attachment side) microtubules (between arrowheads) were
observed near focal contacts (fc) and 10-nm filaments (if) (D) . Nu, nucleus . x 46,000 .
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￿
Fluorescence micrographs of cells microinjected with
DM3B3 after it had been absorbed with CCL-146 vimentin (A and
8) or absorbed with chick brain microtubules (C and D) . Each pair,
A-8 and C-D, represents the same cell stained for the distribution
of DM3B3 with FITC labeled goat anti-mouse (A and C) and for the
distribution of the vimentin filaments with TMRITC-labeled antivi-
mentin-#240 (B and D) 1 .5 h after injection . When DM3B3 was
absorbed with vimentin and then microinjected, the filaments
capped (A and 8) . However, when DM3B3 was absorbed with
microtubules and then injected, filament capping was abolished (C
and D) . x 480.
Microlabeling with (35S]Methionine of
Microinjected Cells
To determine the metabolic erects of microinjecting anti-
tubulins on protein synthesis, we labeled microinjected cells
with [ 35S]methionine and then analysed by two-dimensional
gel electrophoresis. Between 20-30 cells were microinjected
on small (< 1 mmZ) glass chips, then labeled in a small volume
(10 ~1), and analysed on two-dimensional gels as described in
the Materials and Methods section. Cells that were analysed
had been microinjected with the monoclonal or polyclonal
antitubulins, microinjection buffer, or had not received any
injection . In all cases, the microinjected cells continued to
incorporate [ 35S]methionine into their proteins in virtually an
identical pattern to the control-uninjected cells (Fig. 12, A
and B). The incorporation of [35S]methionine into alpha- or
beta-tubulin in injected or control cells appeared to be the
same (Fig. 12, C and D) . In some cases, the labeling of
vimentin appeared to be slightly increased in experiments in
which the microinjected antibody induced 10-nm filament
disorganization (Fig. 12, C and D) .
Recently several laboratories have reported generating mon-
oclonal antibodies to tubulin (1, 29, 38, 63) . We have gener-
ated five monoclonal antibodies and one polyclonal antibody
to tubulin and microinjected these antibodies into cells . Only
two of the monoclonals, one directed against alpha-tubulin
(DM1A) and one against beta-tubulin (DM3B3), and the
polyclonal antibody (GP1T4) caused the 10-nm filaments to
collapse into aggregates within 1 .5 h after microinjection . The
majority of these lateral aggregates appeared to collapse more
FIGURE 12
￿
Fluorograms of two-dimensional gels analysing 25 injected cells (A and C) and 25 control-uninjected cells (B and D)
microlabeled with [' SS]methionine according to the procedures detailed in the Materials and Methods . These experiments were
done to determine the metabolic consequences of 10-nm filament disruption caused by microinjecting antitubulins (i.e, DM1A,
DM3B3, GP1T4) into cells . (A) Fluorogram of the [ 35S]methionine-labeled proteins of 25 cells microinjected with GP1T4; total
counts applied were 121,965 cpm and the exposure was 1 month at -70°C . The area bracketed in A is enlarged in C. (B)
Fluorogram of the ['SS]methionine-labeled proteins of 25 cells that were not injected ; total counts applied were 119,775 cpm
and the exposure was for 1 month at -70°C . The area bracketed in 8 is enlarged in D . In comparing the proteins of the injected
cells versus the controls virtually an identical pattern was observed . When comparing the regions that contain actin (A), vimentin
(V), alpha-tubulin (a), and beta-tubulin (ß) in the injected (C) and control (D) cells there appears to be a slight increase in vimentin
labelling in injected cells . This was occasionally observed in cells in which the microinjected antibody produced 10-nm filament
disruption . Cells that were microinjected with buffer or other antibodies produced patterns indistinguishable from the controls .
Isoelectric focusing was a 5-7 pH gradient and SDS 10% polyacrylamide gel electrophoresis was the second dimention . All
fluorograms were developed, photographed, and printed under identical conditions .
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DISCUSSIONslowly (1 .5 h) and were not observed in studies in which the
tight 10-nm filament caps were produced (10-15 min) in cells
injected with antibodies directed against the vimentin cyto-
skeleton (23, 39, 46). The mechanism by which the antitu-
bulin antibodies caused disorganization ofthe 10-nm filament
system may have been initiated by a brieftransient depolym-
erization of cytoplasmic microtubules within the first 30 min
after antibody microinjection, since by immunofluorescence
microscopy the central distribution of cytoplasmic microtu-
bules was hard to evaluate. Electron microscopy of injected
cells at this time detected assembled microtubules near the
nucleus as well as the cell periphery although these observa-
tions were not quantitative. However, by the time filament
disorganization had reached completion (1 .5 h) the cytoplas-
mic array of microtubules appeared intact. By immunofluo-
rescence these antibodies did not inhibit microtubules from
assembling into a metaphase spindle in cells microinjected in
early prophase and, in preliminary experiments, they did not
block the temperature-dependent assembly of microtubules
(S. H. Blose and F. Matsumura, manuscript in preparation).
We abandoned the use of Taxol to stabilize cytoplasmic
microtubules before microinjection because we found (un-
published observations) as others have (25), that Taxol treat-
ment induces 10-nm filament disorganization. Therefore, it
is possible that the injected antibodies may have exerted their
effect by coating the microtubules. This could then disrupt
the 10-nm filament-microtubule interactions, postulated by
several structural (4, 8, 17, 24, 26, 32, 53, 55, 58) and
biochemical studies (43, 54, 55). Because only certain anti-
bodies to tubulin produced an effect, it may be likely that
these antibodies were directed against only certain sites on
the microtubules seemingly involved in 10-nm filament in-
teractions.
Many agents have been shown to alterthe 10-nm filament
distribution in cells, such as viral infection (2), heat shock
(42, 61), butyrate ion (34), vanadate ion (64), cycloheximid
(56), an uncoupler of oxidative phosphorylation, carbonyl-
cyanide p-trifluoromethoxyphenylhydrazone (48), diphtheria
toxin and exotoxin-A (56), androgen treatment (49), nerve
growth factor (44), A1C13 (47), ultra-violet irridation (36), and
muscle hypertrophy (3, 20, 21). These agents appear to alter
cellular metabolism although the exact mechanism by which
they change 10-nm filament distribution has yet to be eluci-
dated. In the present study, we examined the metabolism of
microinjected cells by microlabeling with [35S]methionine-
No apparent dil~erences could be detected between microin-
jected and control cells in the labeling of their proteins on
two-dimensional gels-with one exception. In several experi-
ments the synthesis of vimentin appeared to be slightly in-
creased. The basis for this is not known, but might reflect the
perturbation ofthe vimentin-l0-nm filaments. It is ofinterest
to note that perturbations of the apparent subunit pool of
tubulin by microinjection of tubulin into living cells specifi-
cally alters the rate of tubulin synthesis in these cells (16). It
is possible that the rate of vimentin synthesis is modulated by
an intact viméntin-l0-nm filament array. In any case, these
metabolic studies did demonstrate that microinjected cells
continue normal protein synthesis as a sign of their vitality
and that 10-nm filament collapse was not a sign of mortality.
Because each monoclonal antibody reacts with a relatively
small region of the tubulin molecule, it is possible that two
(DMIA, DM3B3) react with important sites involved with
10-nm filament interaction and the other three presumably
do not interact with such sites. This is illustrated in Fig. 7, G-
J, where it is clear the monoclonal antibody binds to the
microtubules afterinjection but has no apparent effect on 10-
nm filament distribution. Although we do not understand
how the monoclonal antibodies disrupt the 10-nm filament
distribution (as shown in this study) due to their high speci-
ficity for tubulin and no other molecule, it seems very likely
that these results offer direct evidence for the existence of 10-
nm filament-microtubule interaction.
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Note Added in Proof
￿
After this manuscript was accepted
Wehland and Willingham (Wehland, J-, and M. C. Wil-
lingham, 1983, J. Cell Biol., 97:1476-1490) reported that
microinjection into cells of a concentrated monoclonal anti-
body against tyrosylated alpha-tubulin caused the 10-nm fil-
aments to from perinuclear bundles and the microtubules to
form perinuclear aggregates.
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